JVS Author Spotlight - Aridi, Motaganahalli, Nagarsheth, and Madabhushi
Audible Bleeding editor Wen (@WenKawaji) is joined by 3rd year medical student Nishi (@Nishi_Vootukuru), 2nd year vascular fellow Donna, JVS editor Dr. Forbes (@TL_Forbes), and JVS-CIT editor Dr. Matt Smeds (@mattsmeds) to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Aridi, Dr. Motaganahalli, Dr. Nagarsheth, and Dr. Madabhushi, the authors of the following papers.  Articles:  Physicians preference for carotid revascularization impacts postoperative stroke and death outcomes Simultaneous percutaneous transmural arterial bypass and deep venous arterialization for treatment of critical limb ischemia   Show Guests Dr. Hanaa Aridi (@aridi_hanaa)- PGY3 at Indiana University School of Medicine Dr. Raghu L. Motaganahalli (@Rmotaganahalli)- Professor of Surgery at the Indiana University School of Medicine and an attending Surgeon at the Indiana University Methodist Hospital. He is the Division Chief of Vascular Surgery and the Program Director of vascular surgery training program Dr. Nagarsheth (@KNagarshethMD) -Associate Professor of Surgery and Associate Program Director of Vascular Surgery Fellowship Program at the University of Maryland Medical Center in Baltimore. Program director of the integrated vascular surgery program. Dr. Madabhushi -Vascular Surgery Fellow at the University of Maryland Medical Center in Baltimore Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey. Â
-------- Â
41:47
The Improve AD Trial
Dr. Ezra Schwartz (@ezraschwartz10) interviews Dr. Firas Mussa and Mr. Jake Howitt to discuss the IMPROVE-AD Trial, a landmark, multi-institutional study investigating treatment strategies for uncomplicated Type B Aortic Dissection (uTBAD). The IMPROVE-AD Trial is a multicenter randomized trial funded by the NIH/NHLBI that compares thoracic endovascular aortic repair (TEVAR) plus optimal medical therapy (OMT) vs. OMT and surveillance with selective TEVAR in patients with uncomplicated TBAD. The trial aims to address critical gaps in evidence left by prior studies (INSTEAD-XL, ADSORB), with a unique focus on quality of life, cost-effectiveness, and genetic data. Dr. Firas Mussa is a professor of Surgery at McGovern Medical School at UTHealth Houston. He previously served as the Director of the Vascular Surgery Residency and Fellowship programs at NYU Langone Health. Dr. Mussa earned his medical degree from the University of Baghdad, followed by general surgery training at Johns Hopkins University and a vascular surgery fellowship at Baylor College of Medicine. His research focuses on complex aortic pathology, and he serves as the principal investigator of the IMPROVE AD trial. Mr. Jake Howitt is the Community Engagement Co-Chair of the IMPROVE AD trial and a leading patient advocate within the PCORI-funded Aortic Dissection Collaborative. As a survivor of aortic dissection, he is passionate about improving patient-provider communication and raising awareness of hereditary aortic disease. His work emphasizes the importance of education, empathy, and community-building in clinical research and care delivery. Special thank you to Jacob Soucy (@JacobWSoucy). Resources: ·      Treatment of Uncomplicated Type B Aortic Dissection: Optimal Medical Therapy vs TEVAR + Optimal Medical Therapy- https://journals.sagepub.com/doi/10.1177/15385744231184671?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed ·      INSTEAD Trial - https://pubmed.ncbi.nlm.nih.gov/19996018/ ·      INSTEAD-XL 5-Year Follow-Up - https://pubmed.ncbi.nlm.nih.gov/23922146/ ·      ADSORB Trial - https://pubmed.ncbi.nlm.nih.gov/24962744/ ·      Feasibility of a proposed randomized trial in patients with uncomplicated descending thoracic aortic dissection: Results of worldwide survey - https://pubmed.ncbi.nlm.nih.gov/27823685/ ·      Treatment of AD: Meta-Analysis - https://pubmed.ncbi.nlm.nih.gov/29066151/ ·      TEVAR vs Medical Therapy- https://pubmed.ncbi.nlm.nih.gov/36334259/ ·      IMPROVE AD Trial website - https://improvead.org ·      John Ritter Foundation for Aortic Health - https://johnritterfoundation.org ·      Think Aorta US - https://thinkaorta.us  Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey. *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.   Â
-------- Â
40:15
JVS CIT Editorials and Abstracts - April 2025
In this episode, we spotlight editorials and abstracts from the Journal of Vascular Surgery Cases, Innovations, and Techniques (JVS-CIT). Editorials and Abstracts are read by Authors as well as members of the SVS Social Media Ambassadors.  Guests: Antonio L. Solano, MD (@solanotono) Rotational flap versus long plantar flap for transmetatarsal amputation closure following revascularization  Lucerne milestone approach for benchmarking and education: Towards ultra-low dose endovascular aortic repair  The use of stent grafts for management of junctional vascular injuries: Is this accepted practice?  Hosts: John Culhane (@JohnCulhaneMD)   Follow us @audiblebleeding  Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.
-------- Â
23:17
JVS Author Spotlight - Fereydooni and Satam
Audible Bleeding editor Wen (@WenKawaji) is joined by first year vascular fellow Eva (@urrechisme), JVS editor Dr. Forbes (@TL_Forbes), to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Fereydooni and Dr. Satam, the authors of the following paper.  Articles:  Comparison of EndoSuture vs fenestrated aortic aneurysm repair in treatment of abdominal aortic aneurysms with unfavorable neck anatomy   Show Guests Dr. Arash Fereydooni: PGY5 integrated vascular resident at Stanford Dr. Keyuree Satam: PGY2 integrated vascular resident at Stanford @StanfordVasc Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.
-------- Â
20:33
Fellowship Series - 6 Months In
In this episode we catch up with first-year fellows Imani, Yasong, Wen, and Seth as they recap the first 6 months of training and the transition from general surgery to vascular surgery. They recount learning their way around new hospitals, navigating new cities, and settling into life as vascular surgeons.  Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.
Audible Bleeding is a resource for trainees and practicing vascular surgeons, focusing on interviews with leaders in the field, board preparation, and dissemination of best clinical practices and high impact innovations in vascular surgery.
South Africa